Comparison of Prasugrel and Clopidogrel Used as Antiplatelet Medication for Endovascular Treatment of Unruptured Intracranial Aneurysms: A Meta-Analysis

REFERENCES

1. 1.↵
   2. Yamada NK,
   3. Cross DT 3rd.,
   4. Pilgram TK, et al

   . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82 doi:10.3174/ajnr.A0641 pmid:17885244

   Abstract/FREE Full Text
2. 2.↵
   2. Kang HS,
   3. Han MH,
   4. Kwon BJ, et al

   . Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? Neurosurgery 2010;67:1371–76; discussion 1376 doi:10.1227/NEU.0b013e3181efe3ef pmid:20871459

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Hall R,
   3. Mazer CD

   . Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011;112:292–318 doi:10.1213/ANE.0b013e318203f38d pmid:21212258

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Wiviott SD

   . Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? Cardiol Clin 2008;26:629–37 doi:10.1016/j.ccl.2008.07.003 pmid:18929236

   CrossRefPubMed
5. 5.↵
   2. Moher D,
   3. Liberati A,
   4. Tetzlaff J, et al

   ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–41 doi:10.1016/j.ijsu.2010.02.007 pmid:20171303

   CrossRefPubMed
6. 6.↵
   2. Wells G,
   3. Shea B,
   4. O'Connell D

   . The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonradomized Studies in Meta-Analyses. Ottawa: Ottawa Hospital Research Institute; 2011
7. 7.↵
   2. Akbari SH,
   3. Reynolds MR,
   4. Kadkhodayan Y, et al

   . Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg 2013;5:337–43 doi:10.1136/neurintsurg-2012-010334 pmid:22555594

   Abstract/FREE Full Text
8. 8.↵
   2. Cho WS,
   3. Lee J,
   4. Ha EJ, et al

   . Low-dose prasugrel vs clopidogrel-based tailored premedication for endovascular treatment of cerebral aneurysms. Neurosurgery 2018 Aug 20. [Epub ahead of print] doi:10.1093/neuros/nyy341 pmid:30137613

   CrossRefPubMed
9. 9.↵
   2. Kim CH,
   3. Hwang G,
   4. Kwon OK, et al

   . P2Y12 reaction units threshold for implementing modified antiplatelet preparation in coil embolization of unruptured aneurysms: a prospective validation study. Radiology 2017;282:542–51 doi:10.1148/radiol.2016160542 pmid:27603789

   CrossRefPubMed
10. 10.↵
    2. Sedat J,
    3. Chau Y,
    4. Gaudart J, et al

    . Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms. Interv Neuroradiol 2017;23:52–59 doi:10.1177/1591019916669090 pmid:27760885

    CrossRefPubMed
11. 11.
    2. Lee K,
    3. Park H,
    4. Park I, et al

    . Y-configuration stent-assisted coil embolization for wide-necked intracranial bifurcation aneurysms. J Cerebrovasc Endovasc Neurosurg 2016;18:355–62 doi:10.7461/jcen.2016.18.4.355 pmid:28184345

    CrossRefPubMed
12. 12.↵
    2. Stetler WR,
    3. Chaudhary N,
    4. Thompson BG, et al

    . Prasugrel is effective and safe for neurointerventional procedures. J Neurointerv Surg 2013;5:332–36 doi:10.1136/neurintsurg-2012-010302 pmid:22619468

    Abstract/FREE Full Text
13. 13.↵
    2. Lee D,
    3. Song Y,
    4. Han M, et al

    . Low-dose prasugrel in patients with resistance to clopidogrel for the treatment of cerebral aneurysms. Neurointervention 2018;13:124–27 doi:10.5469/neuroint.2018.01088 pmid:30196683

    CrossRefPubMed
14. 14.↵
    2. Ha EJ,
    3. Cho WS,
    4. Kim JE, et al

    . Prophylactic antiplatelet medication in endovascular treatment of intracranial aneurysms: low-dose prasugrel versus clopidogrel. AJNR Am J Neuroradiol 2016;37:2060–65 doi:10.3174/ajnr.A4864 pmid:27390320

    Abstract/FREE Full Text
15. 15.↵
    2. Caplain H,
    3. Donat F,
    4. Gaud C, et al

    . Pharmacokinetics of clopidogrel. Semin Thromb Hemost 1999;25(Suppl) 2:25–28 pmid:10440419

    PubMedWeb of Science
16. 16.↵
    2. Gurbel PA,
    3. Bliden KP,
    4. Samara W, et al

    . Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST study. J Am Coll Cardiol 2005;46:1827–32 doi:10.1016/j.jacc.2005.07.056 pmid:16286166

    FREE Full Text
17. 17.↵
    2. Kim B,
    3. Kim K,
    4. Jeon P, et al

    . Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2014;35:1786–92 doi:10.3174/ajnr.A3955 pmid:24831597

    Abstract/FREE Full Text
18. 18.↵
    2. Choi HH,
    3. Lee JJ,
    4. Cho YD, et al

    . Antiplatelet premedication for stent-assisted coil embolization of intracranial aneurysms: low-dose prasugrel vs clopidogrel. Neurosurgery 2018;83:981–88 doi:10.1093/neuros/nyx591 pmid:29301051

    CrossRefPubMed